These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24523115)

  • 21. Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases.
    Uchaipichat V; Mackenzie PI; Elliot DJ; Miners JO
    Drug Metab Dispos; 2006 Mar; 34(3):449-56. PubMed ID: 16381668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bovine serum albumin decreases Km values of human UDP-glucuronosyltransferases 1A9 and 2B7 and increases Vmax values of UGT1A9.
    Manevski N; Moreolo PS; Yli-Kauhaluoma J; Finel M
    Drug Metab Dispos; 2011 Nov; 39(11):2117-29. PubMed ID: 21856742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios.
    Williams JA; Hyland R; Jones BC; Smith DA; Hurst S; Goosen TC; Peterkin V; Koup JR; Ball SE
    Drug Metab Dispos; 2004 Nov; 32(11):1201-8. PubMed ID: 15304429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors.
    Walsky RL; Bauman JN; Bourcier K; Giddens G; Lapham K; Negahban A; Ryder TF; Obach RS; Hyland R; Goosen TC
    Drug Metab Dispos; 2012 May; 40(5):1051-65. PubMed ID: 22357286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of UDP-glucuronosyltransferase catalyzed formation of Picroside II glucuronide in microsomes of different species and recombinant UGTs.
    Li T; Zheng Y; Fu F; Ji H; Chen X; Zhao Y; Zhao D; Li N; Zhang L
    Xenobiotica; 2011 Jul; 41(7):530-7. PubMed ID: 21524190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of 3-hydroxydesloratadine.
    Ghosal A; Yuan Y; Hapangama N; Su AD; Alvarez N; Chowdhury SK; Alton KB; Patrick JE; Zbaida S
    Biopharm Drug Dispos; 2004 Sep; 25(6):243-52. PubMed ID: 15334623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic characterization of the 1A subfamily of recombinant human UDP-glucuronosyltransferases.
    Luukkanen L; Taskinen J; Kurkela M; Kostiainen R; Hirvonen J; Finel M
    Drug Metab Dispos; 2005 Jul; 33(7):1017-26. PubMed ID: 15802387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucuronidation of antiallergic drug, Tranilast: identification of human UDP-glucuronosyltransferase isoforms and effect of its phase I metabolite.
    Katoh M; Matsui T; Yokoi T
    Drug Metab Dispos; 2007 Apr; 35(4):583-9. PubMed ID: 17220234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of inhibition potentials of drugs against zidovudine glucuronidation in rat hepatocytes and liver microsomes.
    Mano Y; Usui T; Kamimura H
    Drug Metab Dispos; 2007 Apr; 35(4):602-6. PubMed ID: 17267620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterisation of UDP-glucuronosyltransferase activity in sea turtle
    Dias VHV; Mattos JJ; Bastolla CLV; Lüchmann KH; Bainy ACD
    Xenobiotica; 2022 Dec; 52(12):1011-1019. PubMed ID: 36594659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human UDP-Glucuronosyltransferase (UGT) 2B10: Validation of Cotinine as a Selective Probe Substrate, Inhibition by UGT Enzyme-Selective Inhibitors and Antidepressant and Antipsychotic Drugs, and Structural Determinants of Enzyme Inhibition.
    Pattanawongsa A; Nair PC; Rowland A; Miners JO
    Drug Metab Dispos; 2016 Mar; 44(3):378-88. PubMed ID: 26669329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complexities of glucuronidation affecting in vitro in vivo extrapolation.
    Lin JH; Wong BK
    Curr Drug Metab; 2002 Dec; 3(6):623-46. PubMed ID: 12369890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Posttranscriptional regulation of uridine diphosphate glucuronosyltransferases.
    Riches Z; Collier AC
    Expert Opin Drug Metab Toxicol; 2015 Jun; 11(6):949-65. PubMed ID: 25797307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effects of uridine diphosphate on UDP-glucuronosyltransferase.
    Yokota H; Ando F; Iwano H; Yuasa A
    Life Sci; 1998; 63(19):1693-9. PubMed ID: 9806225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of aflatoxins on UDP-glucuronosyltransferases (UGTs).
    Du Z; Liu ZZ
    Toxicol In Vitro; 2023 Aug; 90():105612. PubMed ID: 37164184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of human UGT isoforms responsible for glucuronidation of efavirenz and its three hydroxy metabolites.
    Bae SK; Jeong YJ; Lee C; Liu KH
    Xenobiotica; 2011 Jun; 41(6):437-44. PubMed ID: 21319958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance.
    Miners JO; Polasek TM; Hulin JA; Rowland A; Meech R
    Pharmacol Ther; 2023 Aug; 248():108459. PubMed ID: 37263383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examining Physiologically Based Pharmacokinetic Model Assumptions for Cross-Tissue Similarity of Activity per Unit of Enzyme: The Case Example of Uridine 5'-Diphosphate Glucuronosyltransferase.
    Ahmed AN; Rostami-Hodjegan A; Barber J; Al-Majdoub ZM
    Drug Metab Dispos; 2022 Aug; 50(8):1119-1125. PubMed ID: 35636771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the UDP-glucuronosyltransferases involved in the glucuronidation of an antithrombotic thioxyloside in rat and humans.
    Pless D; Gouze JN; Senay C; Herber R; Leroy P; Barberousse V; Fournel-Gigleux S; Magdalou J
    Drug Metab Dispos; 1999 May; 27(5):588-95. PubMed ID: 10220487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms.
    Zhu L; Ge G; Zhang H; Liu H; He G; Liang S; Zhang Y; Fang Z; Dong P; Finel M; Yang L
    Drug Metab Dispos; 2012 Mar; 40(3):529-38. PubMed ID: 22180045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.